Share

December 17, 2014Article

Increased risk of Bell palsy in patients with migraine

A nationwide cohort study

Kuan-Po Peng, Yung-Tai Chen, Jong-Ling Fuh, Chao-Hsiun Tang, Shuu-Jiun Wang
First published December 17, 2014, DOI: https://doi.org/10.1212/WNL.0000000000001124
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
363

Share

Article Information

10.1212/WNL.0000000000001124
DOI: 
https://doi.org/10.1212/WNL.0000000000001124
PubMed: 
25520313
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 10, 2014
  • Accepted in final form July 28, 2014
  • First Published December 17, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Kuan-Po Peng, MD*,
    2. Yung-Tai Chen, MD*,
    3. Jong-Ling Fuh, MD,
    4. Chao-Hsiun Tang, PhD and
    5. Shuu-Jiun Wang, MD
  1. Kuan-Po Peng, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Yung-Tai Chen, MD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jong-Ling Fuh, MD,
    4. Scientific Advisory Boards:

    1. Served on the advisory boards for Elli Lilly

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Eli Lilly (IDENTITY2 drug trial, 2009)

    Research Support, Government Entities:

    1. Funding from Taiwan National Science Council and Taipei Veterans General Hospital

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Chao-Hsiun Tang, PhD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Shuu-Jiun Wang, MD
    6. Scientific Advisory Boards:

    1. (1) Allergan Taiwan (2) Eli Lilly Taiwan

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Pfizer Taiwan (2) Elli Lilly Taiwan (3) GSK Taiwan

    Editorial Boards:

    1. Editor, Journal of the Chinese Medical Association, 2005- Associate editor, Cephalalgia, 2009- Associate editor for headache, MedLink Neurology, 2009- Co-Editor, Acta Neurologica Taiwanica, 2001-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Science Council of Taiwan (NSC 102-2321-B-010- 030, 100-2314-B-010-018-MY3, and 99-2314-B-075-036-MY3) (2) Taipei-Veterans General Hospital (VGHUST102-G7-6-1, V102C-118 , V102E9-001) (3) NSC support for Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 101-2911-I-008-001), Brain Research Center, National Yang- Ming University and a grant from Ministry of Education, Aim for the Top University Plan.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Taiwan Headache Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Internal Medicine (K.-P.P.), Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan; Institute of Brain Science (K.-P.P., S.-J.W.), National Yang-Ming University, Taipei; Faculty of Medicine (K.-P.P., Y.-T.C., J.-L.F., S.-J.W.), National Yang-Ming University School of Medicine, Taipei; Department of Nephrology (Y.-T.C.), Institute of Internal Medicine, Taipei City Hospital Heping Fuyou Branch, Taipei; Department of Neurology (J.-L.F., S.-J.W.), Neurological Institute, Taipei Veterans General Hospital, Taipei; and School of Health Care Administration (C.-H.T.), Taipei Medical University, Taipei, Taiwan.
  1. Correspondence to Dr. Wang: sjwang{at}vghtpe.gov.tw

Article usage

Article usage: December 2014 to February 2023

AbstractFullPdfSource
Dec 20141025037Highwire
Jan 201523513779Highwire
Feb 2015534337110Highwire
Mar 2015321310Highwire
Apr 2015199310Highwire
May 201513744Highwire
Jun 201514440Highwire
Jul 201515675Highwire
Aug 201512721Highwire
Sep 201514176Highwire
Oct 201512775Highwire
Nov 201512122Highwire
Dec 201510113Highwire
Jan 201611701Highwire
Feb 20169200Highwire
Mar 20166901Highwire
Apr 20166511Highwire
May 20165313Highwire
Jun 20165523Highwire
Jul 20164700Highwire
Aug 20166811Highwire
Sep 20166511Highwire
Oct 20167414Highwire
Nov 20167700Highwire
Dec 20165700Highwire
Jan 20175701Highwire
Feb 20177224Highwire
Mar 20176200Highwire
Apr 20177700Highwire
May 20177512Highwire
Jun 20176011Highwire
Jul 20175100Highwire
Aug 20175100Highwire
Sep 20175800Highwire
Oct 20175711Highwire
Nov 20175322Highwire
Dec 20177114Highwire
Jan 20187233Highwire
Feb 20187121Highwire
Mar 20188511Highwire
Apr 201824922Highwire
May 20189501Highwire
Jun 201810311Highwire
Jul 20188202Highwire
Aug 20188101Highwire
Sep 20188701Highwire
Oct 20186610Highwire
Nov 201810101Highwire
Dec 201812611Highwire
Jan 20198300Highwire
Feb 201910501Highwire
Mar 20195323Highwire
Apr 20197622Highwire
May 20198311Highwire
Jun 20194712Highwire
Jul 20195321Highwire
Aug 20194711Highwire
Sep 20194932Highwire
Oct 20199411Highwire
Nov 20198300Highwire
Dec 2019104275Highwire
Jan 20209315Highwire
Feb 20203111Highwire
Mar 20204910Highwire
Apr 20202400Highwire
May 20203300Highwire
Jun 20206310Highwire
Jul 20204100Highwire
Aug 20207511Highwire
Sep 20208021Highwire
Oct 202010621Highwire
Nov 20208711Highwire
Dec 202011311Highwire
Jan 20216100Highwire
Feb 20218800Highwire
Mar 202110004Highwire
Apr 20217110Highwire
May 20219400Highwire
Jun 20216600Highwire
Jul 20218000Highwire
Aug 20216300Highwire
Sep 20214700Highwire
Oct 20215201Highwire
Nov 20216500Highwire
Dec 20216210Highwire
Jan 20225401Highwire
Feb 20226210Highwire
Mar 20223911Highwire
Apr 20225000Highwire
May 20224501Highwire
Jun 20224920Highwire
Jul 20223801Highwire
Aug 20225421Highwire
Sep 20226410Highwire
Oct 20227012Highwire
Nov 20227503Highwire
Dec 20224711Highwire
Jan 20234800Highwire
Feb 20236000Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles